Navigation Links
SIRO Group Appoints Scott L. Spector as President, Strategic Operations, for its European Business
Date:5/26/2009

New appointment brings in key leadership expertise to strengthen its European business

OFFENBACH MAIN, Germany, May 26 /PRNewswire/ -- SIRO ClinPharm Pvt. Ltd., a leading multinational full service Contract Research Organization (CRO), today announced the appointment of Scott L. Spector as President Strategic Operations Europe. Mr. Spector will be based in the Offenbach, Germany office of Omega Mediation.

Mr. Spector brings to Omega Mediation more than 15 years of international CRO experience. Prior to joining Omega Mediation, Mr. Spector served as Chief Executive Officer of AAI Oncology & General Manager of AAI Pharma France which is an oncology focused multinational Contract Research Organization headquartered in Paris, France. Mr. Spector was responsible for the strategic direction of the oncology operations, business development and clinical operations.

"We are delighted to have someone of Scott's caliber on board," said Dr. Chetan Tamhankar, Chief Operating Officer, SIRO Group. "This move is in alignment with our strategy and is bound to give an impetus to our international capabilities. Scott's leadership will contribute substantially to our efforts in becoming a fully-integrated global leader in the provision of clinical research services."

Sofia Hofmann, President Europe said, "Scott's senior management and leadership experience in the European CRO sector will be a valuable asset in pursuing our growth objectives and expansion plans for the business. I am confident he will bring in valuable business insights and help identify future growth opportunities."

"Joining Omega Mediation at this stage in its transformation to a multinational CRO is a tremendous opportunity," said Mr. Spector. "I look forward to working with Dr. Tamhankar and Mrs. Hofmann and the team to execute on our strategy to grow the organization and build shareholder value."

Prior to joining AAI Pharma, Mr. Spector was at Quintiles Transnational Corp., the world's largest CRO where he held positions of increasing responsibility over a 9-year period, serving as General Manager for their Paris, France office and Global Finance Director for the CNS and Anti Infective business units. Mr. Spector played a key role in integrating newly acquired businesses, growing operations, implementing business management practices and improving operating efficiencies.

About SIRO

SIRO ClinPharm Private Limited (SIRO) is among one of the leading multinational CROs, offering full scope services, conducting clinical trials in the pharmaceutical, biotechnology and medical devices sectors in compliance with international standards. SIRO is one of the first CROs founded in India and caters to the needs of pharmaceutical companies across the world. The company has offices in India, the United States, Israel and in Europe at Germany, Romania, Estonia & Greece.


'/>"/>
SOURCE SIRO ClinPharm
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Simcere Pharmaceutical Group Announces Agreement to Acquire 37.5% Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
2. DFG establishes 14 new research training groups
3. Health Strategies Group Forecasts Emerging Trends in Future Sales Force Models at the SPBT 2009 Conference
4. Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement
5. Simcere Pharmaceutical Group Appoints Dr. Peng Wang as Chief Scientific Officer
6. Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results
7. Tiens Biotech Group (USA) Reports First Quarter Results
8. Adipose-derived Stem Cells Could Help Traumatic Brain Injury Patients, Says Bio-Matrix Scientific Groups, Entest BioMedical Inc. Researcher
9. CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems
10. Nanosys Licenses Nanowire Technology to QuantuMDx Group for Next Generation Diagnostic and Sequencing Technologies
11. The Chiesi Group Lands in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... They call it ... biological network, a depiction of a system of linkages and connections so complex ... associate professor of computer science at Worcester Polytechnic Institute (WPI) and director of ...
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont ... today that they have entered into a multiyear collaboration to identify and characterize ... with additional tools for gene editing across all applications. , Under the terms ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Market with the addition of its newest module, US Hemostats & Sealants. , ... thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in ...
(Date:10/12/2017)... , ... October 12, 2017 ... ... has launched Rosalindâ„¢, the first-ever genomics analysis platform specifically designed for life ... Named in honor of pioneering researcher Rosalind Franklin, who made a major ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):